GeneDx Announces Closing of Underwritten Public Offering and Concurrent Registered Direct OfferingGlobeNewsWire • 01/31/23
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene DiscoveryGlobeNewsWire • 01/30/23
GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct OfferingGlobeNewsWire • 01/27/23
GeneDx Announces Proposed Underwritten Public Offering of Class a Common Stock and Concurrent Registered Direct OfferingGlobeNewsWire • 01/26/23